STELLULAR
Live / Applied — Fourth extension granted (statement of use) (as of 15 Dec 2025)
What this means for you
Not registered yet, but its 07 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97708044
- Mark type
- Stylized text
- Filed
- 07 Dec 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Blood platelets and stem cell derived products for medical or clinical use in the nature of pharmaceutical preparations for the treatment of a variety of indications such as ocular surface diseases or injury, chronic wound healing, osteoarthritis, alopecia, and others that platelet-rich plasma is being used to treat; Blood platelet variants for medical or clinical use; Pharmaceutical compositions for drug delivery in the form of topical drops, gel-like/ointment formulations, and injectable solutions comprised of blood platelets, blood platelet variants, and stem cell derived products in the nature of cells or any components of cells that facilitate the delivery of pharmaceutical preparations
Owner
- Stellular Bio, Inc., Watertown, MA, US
- Stellular Bio, Inc., Watertown, MA, US
Prosecution history
- 15 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2025 — SOU EXTENSION 4 GRANTED
- 14 Dec 2025 — SOU EXTENSION 4 FILED
- 14 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jun 2025 — SOU EXTENSION 3 GRANTED
- 02 Jun 2025 — SOU EXTENSION 3 FILED
- 02 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 2 GRANTED
- 20 Nov 2024 — SOU EXTENSION 2 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2024 — SOU EXTENSION 1 GRANTED
- 04 Jun 2024 — SOU EXTENSION 1 FILED